Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer.

Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boitnott JK, Seidler AJ, Coleman J.

Am J Surg. 1991 Jan;161(1):120-4; discussion 124-5.

PMID:
1987845
2.

Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.

Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe KD, Wolfgang C, Hruban RH, Schulick RD, Yeo CJ, Choti MA.

Surgery. 2007 May;141(5):610-8. Epub 2007 Mar 23.

PMID:
17462460
3.

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.

Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, Dooley WC, Coleman J, Pitt HA.

Ann Surg. 1995 Jun;221(6):721-31; discussion 731-3.

4.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
5.

Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.

Benassai G, Mastrorilli M, Mosella F, Mosella G.

J Exp Clin Cancer Res. 1999 Mar;18(1):23-8.

PMID:
10374672
7.

Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas.

Zacharias T, Jaeck D, Oussoultzoglou E, Neuville A, Bachellier P.

J Gastrointest Surg. 2007 Mar;11(3):350-6.

PMID:
17458610
8.

Survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas.

Benassai G, Mastrorilli M, Quarto G, Cappiello A, Giani U, Mosella G.

Chir Ital. 2000 May-Jun;52(3):263-70.

PMID:
10932371
9.

[Surgical resection of pancreatic cancer].

Magistrelli P, Antinori A, Crucitti A, La Greca A, Coppola R, Nuzzo G, Picciocchi A.

Tumori. 1999 Jan-Feb;85(1 Suppl 1):S22-6. Italian.

PMID:
10235076
10.

Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas.

Benassai G, Mastrorilli M, Quarto G, Cappiello A, Giani U, Forestieri P, Mazzeo F.

J Surg Oncol. 2000 Apr;73(4):212-8.

PMID:
10797334
11.

Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?

Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, Gullerud RE, Donohue JH, Nagorney DM, Farnell MB.

Ann Surg. 2008 Mar;247(3):456-62. doi: 10.1097/SLA.0b013e3181613142.

PMID:
18376190
12.
13.

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD.

J Gastrointest Surg. 2000 Nov-Dec;4(6):567-79.

PMID:
11307091
14.

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, Zahurak ML, Dooley WC, Coleman J, Sauter PK, Pitt HA, Lillemoe KD, Cameron JL.

Ann Surg. 1997 May;225(5):621-33; discussion 633-6.

15.

Accuracy of staging node-negative pancreas cancer: a potential quality measure.

Tomlinson JS, Jain S, Bentrem DJ, Sekeris EG, Maggard MA, Hines OJ, Reber HA, Ko CY.

Arch Surg. 2007 Aug;142(8):767-723; discussion 773-4.

PMID:
17709731
16.
17.

Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection.

Riediger H, Makowiec F, Fischer E, Adam U, Hopt UT.

J Gastrointest Surg. 2006 Sep-Oct;10(8):1106-15.

PMID:
16966029
18.

Intraoperative allogeneic red blood cell transfusion in ampullary cancer outcome after curative pancreatoduodenectomy: a clinical study and meta-analysis.

Yao HS, Wang Q, Wang WJ, Hu ZQ.

World J Surg. 2008 Sep;32(9):2038-46. doi: 10.1007/s00268-008-9675-9.

PMID:
18584239
19.

Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection.

Delcore R, Rodriguez FJ, Forster J, Hermreck AS, Thomas JH.

Am J Surg. 1996 Nov;172(5):463-8; discussion 468-9.

PMID:
8942545
20.

Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer.

Tachibana M, Tabara H, Kotoh T, Kinugasa S, Dhar DK, Hishikawa Y, Masunaga R, Kubota H, Nagasue N.

Am J Gastroenterol. 1999 Mar;94(3):757-65.

PMID:
10086663

Supplemental Content

Support Center